Bdh Industries (BDH) | Financial Analysis & Statements
Bdh Industries Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
186.2M
Gross Profit
48.8M
26.19%
Operating Income
19.0M
10.21%
Net Income
18.3M
9.81%
EPS (Diluted)
₹3.17
Balance Sheet Metrics
Total Assets
869.4M
Total Liabilities
181.8M
Shareholders Equity
687.6M
Debt to Equity
0.26
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Bdh Industries Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 648.9M | 848.4M | 738.4M | 685.5M | 563.3M |
| Cost of Goods Sold | 414.0M | 602.8M | 496.8M | 489.8M | 371.8M |
| Gross Profit | 234.9M | 245.6M | 241.5M | 195.7M | 191.5M |
| Gross Margin % | 36.2% | 29.0% | 32.7% | 28.6% | 34.0% |
| Operating Expenses | |||||
| Research & Development | 2.3M | 3.0M | 3.8M | 2.3M | 2.4M |
| Selling, General & Administrative | 15.8M | 13.8M | 19.8M | 14.5M | 11.6M |
| Other Operating Expenses | 42.0M | 39.7M | 44.5M | 29.8M | 40.4M |
| Total Operating Expenses | 60.1M | 56.5M | 68.1M | 46.7M | 54.5M |
| Operating Income | 107.0M | 118.5M | 103.8M | 84.5M | 77.2M |
| Operating Margin % | 16.5% | 14.0% | 14.1% | 12.3% | 13.7% |
| Non-Operating Items | |||||
| Interest Income | 18.4M | 15.8M | 8.4M | 8.8M | 13.0M |
| Interest Expense | 730.0K | 1.8M | 1.6M | 2.3M | 2.8M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 124.7M | 132.5M | 110.7M | 95.5M | 87.5M |
| Income Tax | 31.9M | 33.8M | 28.6M | 23.3M | 23.9M |
| Effective Tax Rate % | 25.6% | 25.5% | 25.9% | 24.4% | 27.3% |
| Net Income | 92.7M | 98.7M | 82.0M | 72.2M | 63.6M |
| Net Margin % | 14.3% | 11.6% | 11.1% | 10.5% | 11.3% |
| Key Metrics | |||||
| EBITDA | 134.5M | 140.1M | 117.9M | 99.6M | 98.2M |
| EPS (Basic) | ₹16.11 | ₹17.14 | ₹14.25 | ₹12.55 | ₹11.05 |
| EPS (Diluted) | ₹16.11 | ₹17.14 | ₹14.25 | ₹12.55 | ₹11.05 |
| Basic Shares Outstanding | 5756238 | 5757300 | 5757300 | 5757300 | 5757300 |
| Diluted Shares Outstanding | 5756238 | 5757300 | 5757300 | 5757300 | 5757300 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Bdh Industries Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 307.1M | 246.3M | 253.8M | 181.7M | 219.5M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 141.8M | 283.6M | 166.4M | 145.2M | 151.8M |
| Inventory | 73.9M | 50.0M | 71.6M | 67.1M | 54.3M |
| Other Current Assets | 10.0K | 10.0K | 10.0K | 17.0K | 16.0K |
| Total Current Assets | 667.5M | 725.7M | 604.8M | 491.0M | 505.4M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 146.9M | 145.9M | 131.4M | 131.4M | 131.9M |
| Goodwill | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 1.8M | 1.0K | 1.0K | 2.0M | 456.0K |
| Total Non-Current Assets | 201.9M | 208.4M | 195.4M | 198.1M | 203.5M |
| Total Assets | 869.4M | 934.1M | 800.3M | 689.1M | 709.0M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 151.5M | 211.2M | 189.2M | 164.5M | 174.4M |
| Short-term Debt | 9.8M | 86.9M | 48.5M | 22.5M | 85.1M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 728.0K | 728.0K | 928.0K | 728.0K | 817.0K |
| Total Current Liabilities | 169.2M | 306.6M | 246.1M | 195.9M | 269.5M |
| Non-Current Liabilities | |||||
| Long-term Debt | - | - | - | - | - |
| Deferred Tax Liabilities | 10.6M | 4.4M | 360.0K | 466.0K | 349.0K |
| Other Non-Current Liabilities | - | - | 5.5M | 5.5M | 5.5M |
| Total Non-Current Liabilities | 12.6M | 6.0M | 7.2M | 7.4M | 8.8M |
| Total Liabilities | 181.8M | 312.5M | 253.3M | 203.3M | 278.3M |
| Equity | |||||
| Common Stock | 57.6M | 57.6M | 57.6M | 57.6M | 59.4M |
| Retained Earnings | 457.6M | 405.5M | 345.4M | 296.5M | 252.0M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 687.6M | 621.6M | 546.9M | 485.9M | 430.7M |
| Key Metrics | |||||
| Total Debt | 9.8M | 86.9M | 48.5M | 22.5M | 85.1M |
| Working Capital | 498.3M | 419.1M | 358.7M | 295.2M | 235.9M |
Balance Sheet Composition
Bdh Industries Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 124.7M | 132.5M | 110.7M | 95.5M | 87.5M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 121.9M | -126.1M | -43.9M | -20.6M | -72.0M |
| Operating Cash Flow | 227.9M | -9.0M | 59.8M | 64.4M | 4.2M |
| Investing Activities | |||||
| Capital Expenditures | -2.1M | -18.9M | -42.0K | 5.0M | -146.0K |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | 0 | 0 | -3.5M | 0 | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -2.1M | -18.9M | -3.5M | 5.0M | -146.0K |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -25.9M | -23.0M | -20.7M | -17.3M | -14.4M |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | -77.1M | - | - | -62.6M | -7.2M |
| Financing Cash Flow | -180.1M | 15.4M | 5.2M | -142.4M | -28.7M |
| Free Cash Flow | 145.6M | -37.6M | 62.9M | 28.0M | 7.7M |
| Net Change in Cash | 45.6M | -12.5M | 61.5M | -73.0M | -24.6M |
Cash Flow Trend
Bdh Industries Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
21.06
Forward P/E
52.92
Price to Book
3.11
Price to Sales
2.59
PEG Ratio
0.87
Profitability Ratios
Profit Margin
12.30%
Operating Margin
13.67%
Return on Equity
13.49%
Return on Assets
10.67%
Financial Health
Current Ratio
4.11
Debt to Equity
0.04
Beta
0.21
Per Share Data
EPS (TTM)
₹18.09
Book Value per Share
₹122.68
Revenue per Share
₹147.22
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| BDH | 2.2B | 21.06 | 3.11 | 13.49% | 12.30% | 0.04 |
| Sun Pharmaceutical | 3.9T | 36.73 | 5.15 | 15.08% | 19.21% | 6.68 |
| Divi's Laboratories | 1.7T | 67.11 | 10.82 | 14.64% | 24.04% | 0.58 |
| Sun Pharma Advanced | 46.7B | -13.65 | -13.55 | 157.88% | -53.22% | -1.21 |
| Innova Captab | 41.4B | 31.20 | 4.05 | 13.37% | 8.85% | 32.95 |
| Gujarat Themis | 35.4B | 73.73 | 13.36 | 19.64% | 29.99% | 27.04 |
Financial data is updated regularly. All figures are in the company's reporting currency.





